Navamedic ASA (FRA:N1A)

Navamedic ASA Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	45	39	57	57	55	28
Market Cap Growth	26.07%	-32.08%	-0.50%	2.95%	99.11%	25.17%
Enterprise Value	68	45	64	59	56	27
Last Close Price	1.75	2.08	3.20	3.19	3.00	1.77
PE Ratio	-	-	-	20.43	899.28	-
PS Ratio	0.99	0.85	1.24	1.57	2.00	1.39
PB Ratio	2.54	2.10	3.10	2.87	3.68	2.26
P/TBV Ratio	-	-	-	7.67	8.84	5.28
P/FCF Ratio	-	12.60	-	38.32	-	-
P/OCF Ratio	36.33	11.54	292.27	33.51	-	-
EV/Sales Ratio	1.47	1.01	1.41	1.64	2.02	1.37
EV/EBITDA Ratio	24.59	12.30	14.65	12.60	34.77	-
EV/EBIT Ratio	74.12	16.81	18.17	14.07	49.01	-
EV/FCF Ratio	-4.53	14.83	-	39.84	-	-
Debt / Equity Ratio	1.49	0.55	0.74	0.28	0.31	0.18
Debt / EBITDA Ratio	9.64	2.55	2.96	1.14	2.57	-
Debt / FCF Ratio	-	3.29	-	3.74	-	-
Asset Turnover	0.87	1.09	1.15	1.07	0.94	0.94
Inventory Turnover	3.30	3.48	3.39	3.09	3.21	3.78
Quick Ratio	0.72	0.66	0.49	0.90	0.78	0.72
Current Ratio	1.49	1.42	1.11	1.93	1.51	1.12
Return on Equity (ROE)	-15.99%	-2.60%	-6.59%	16.31%	0.44%	-15.77%
Return on Assets (ROA)	1.08%	4.08%	5.57%	7.79%	2.43%	-1.38%
Return on Capital (ROIC)	1.47%	5.73%	7.91%	11.91%	4.09%	-2.40%
Return on Capital Employed (ROCE)	1.90%	9.70%	12.50%	17.30%	5.90%	-3.20%
Earnings Yield	-7.12%	-1.21%	-2.15%	4.90%	0.11%	-5.64%
FCF Yield	-32.82%	7.94%	-0.00%	2.61%	-0.36%	-1.15%
Buyback Yield / Dilution	-	-1.24%	-1.48%	-3.60%	-13.61%	-23.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.